featured
Primary Cemiplimab Treatment for Orbital Squamous Cell Carcinoma Is Effective and May Alleviate the Need for Orbital Exenteration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Eye (London, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration
Eye (Lond) 2023 Aug 01;37(12)2482-2487, A Tiosano, M Ben-Ishai, Y Cnaany, G Markel, N Kurman, A Popovtzer, G Bar Sela, G Ben Simon, A Gershoni, I YassurFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.